Hikma's filing for a generic version of GlaxoSmithKline's Advair Diskus has been accepted by the FDA. The abbreviated new drug application (ANDA) for the fluticasone propionate and salmeterol ...
Hikma’s US subsidiary ... a generic version of GSK’s Advair/Seretide (fluticasone+salmeterol), and VR506, a generic, inhaled monotherapy for asthma. Vectura earlier this year merged with ...
Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...
London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Riad Mishlawi, Hikma’s CEO, said: “I am pleased ...
Hikma Pharmaceuticals will acquire parts of Danish firm Xellia Pharmaceuticals, a drug company specialising in injectable ...
Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC: 2100 ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory ...
The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory ...
[13] This current study indicates that when FP is combined with salmeterol, this dose ratio may be even higher. Our study showed that in patients with mild-to-moderate asthma, twice-daily ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...